pharmaceuticals

The United Kingdom-based drug maker wooed doctors with lavish dinners and entertainment.

The move comes more than a week after the state of Oklahoma won its landmark lawsuit against Johnson & Johnson...

The announcement is the latest development as New York-based Bristol-Myers Squibb looks to close on its purchase of Celgene.

A survey found that specialty drugs have an outsized impact on employer prescription drug spending.

The sewering ban, one of the more stringent changes outlined in EPA's rule, is the only part of the rule...

Heyward Donigan takes the reins as Rite Aid and rivals CVS Health and Walgreens Boots Alliance battle to extend their...

Deal with drug company will cap the states' treatment costs.

Although its Aetna acquisition still awaits final approval from a judge, CVS Health cited it and other positive developments for...

A first-of-its-kind intensive training program gives non-specialist pharmacists confidence to deal with complex and critical medication issues for ICU patients.

Critics say authorized generics hurt long-term competition and often perversely increase costs, even in the short term.

The breadth of the plan's impact will depend in large part on proposals brought forward by the industry.

A growing number of health systems and insurers providing real-time drug pricing information to physicians so they can help patients...